Lung cancer is one of the most common types of cancer worldwide and accounts for around one fifth of cancer-related
Continue reading »
Home »
Norgesic
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. NORGESIC™ Tablets Orphenadrine citrate 35mg & Paracetamol
Continue reading »
DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19
RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board
Continue reading »
Prostate cancer regulator plays role in COVID-19, providing a promising treatment lead
By taking a lesson from prostate cancer, researchers now have a promising lead on a treatment for COVID-19. Two proteins,
Continue reading »
Low risk of cancer spread on active surveillance for early prostate cancer
Men undergoing active surveillance for prostate cancer have very low rates – one percent or less—of cancer spread (metastases) or
Continue reading »
My grandad, dad, and uncle all had prostate cancer. Online says your doctor should check you after you’re 40. Given history, should I be checked to see if I have prostate cancer sooner? Is this a blood test? X-ray? How do they check?
Thanks for your question. Prostate cancer is one of the most common forms of cancer among sex-assigned at birth males.
Continue reading »
More prostate cancers are being diagnosed at a later stage
(HealthDay)—While men can take solace in a new government report that shows prostate cancer cases have been declining overall in
Continue reading »
Research shows quality of prostate MRI is highly variable among institutions
Prostate MRI is an emerging technology used to identify and guide treatment for prostate cancer and has recently gained wide
Continue reading »
AI can be used to detect and grade prostate cancer
Researchers at Karolinska Institutet in Sweden and Tampere University in Finland have developed a method based on artificial intelligence (AI)
Continue reading »
Prostate cancer ‘super responders’ live for two years on immunotherapy
Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more
Continue reading »